|
1
|
WU Na-Ming, LI Jun and TAO Juan:
Diagnostic hotspots of malignant melanoma. Diagn Theory Pract
(Chinese). 2:215–220. 2023.
|
|
2
|
Wang JY, Wang EB and Swetter SM: What is
melanoma? JAMA. 329:9482023. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Haydu LE, Lo SN, McQuade JL, Amaria RN,
Wargo J, Ross MI, Cormier JN, Lucci A, Lee JE, Ferguson SD, et al:
Cumulative incidence and predictors of CNS metastasis for patients
with American joint committee on cancer 8th edition stage iii
melanoma. J Clin Oncol. 38:1429–1441. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
National Comprehensive Cancer Network, .
NCCN Guidelines for Ovarian Cancer. NCCN; Philadelphia: 2025
|
|
5
|
Etchevers HC: Hiding in plain sight:
Molecular genetics applied to giant congenital melanocytic nevi. J
Invest Dermatol. 134:879–882. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gerami P and Paller AS: Making a mountain
out of a molehill: NRAS, mosaicism, and large congenital nevi. J
Invest Dermatol. 133:2127–2130. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
National Comprehensive Cancer Network, .
NCCN Guidelines for Melanoma. NCCN; Philadelphia: 2025
|
|
8
|
Gessi M, Hammes J, Lauriola L, Dörner E,
Kirfel J, Kristiansen G, Zur Muehlen A, Denkhaus D, Waha A and
Pietsch T: GNA11 and N-RAS mutations: Alternatives for MAPK pathway
activating GNAQ mutations in primary melanocytic tumours of the
central nervous system. Neuropathol Appl Neurobiol. 4:417–425.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chen HC, Hsu TI, Chao TY and Yang ST:
Neurocutaneous melanosis with meningeal melanocytosis: A rare case
of intracranial hypertension and cutaneous manifestations. Life
(Basel). 14:1392024.PubMed/NCBI
|
|
10
|
Kinsler VA, Thomas AC, Ishida M, Bulstrode
NW, Loughlin S, Hing S, Chalker J, McKenzie K, Abu-Amero S, Sater
O, et al: Multiple congenital melanocytic nevi and neurocutaneous
melanosis are caused by postzygotic mutations in codon 61 of NRAS.
J Invest Dermatol. 9:2229–2236. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jakchairoongruang K, Khakoo Y, Beckwith M
and Barkovich AJ: New insights into neurocutaneous melanosis.
Pediatr Radiol. 48:1786–1796. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Vanood A, Lee YA, Leleszi E and Krishnan
A: Symptomatic neurocutaneous melanosis: Mild clinical onset in a
teenager. BMJ Case Rep. 13:e2357722020. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gerami P, Kim D, Zhang B, Compres EV, Khan
AU, Yazdan P, Guitart J and Busam K: Desmoplastic melanomas
mimicking neurofibromas. Am J Dermatopathol. 42:916–922. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kashani-Sabet M: Molecular markers in
melanoma. Br J Dermatol. 170:31–35. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lee BM and Yang YG: Interpretation of the
European expert consensus-based multidisciplinary melanoma
diagnosis and treatment guideline 2022 edition. J Prac Dermatol
(Chinese). 16:153–155. 2023.
|
|
16
|
Várvölgyi T, Janka EA, Szász I, Koroknai
V, Toka-Farkas T, Szabó IL, Ványai B, Szegedi A, Emri G and Balázs
M: Combining biomarkers for the diagnosis of metastatic melanoma. J
Clin Med. 13:1742023. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Janka EA, Várvölgyi T, Sipos Z, Soós A,
Hegyi P, Kiss S, Dembrovszky F, Csupor D, Kéringer P, Pécsi D, et
al: Predictive performance of serum S100B versus LDH in melanoma
patients: A systematic review and meta-analysis. Front Oncol.
11:7721652021. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Doolan BJ, Robinson AJ, Wolfe R, Kelly JW,
McLean C, McCormack C, Henderson MA and Pan Y: Accuracy of partial
biopsies in the management of cutaneous melanoma. Australas J
Dermatol. 60:209–213. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Randic T, Kozar I, Margue C, Utikal J and
Kreis S: NRAS mutant melanoma: Towards better therapies. Cancer
Treat Rev. 99:1022382021. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Valpione S and Campana LG: Immunotherapy
for advanced melanoma: Future directions. Immunotherapy. 8:199–209.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Klobuch S, Seijkens TTP, Schumacher TN and
Haanen JBAG: Tumour-infiltrating lymphocyte therapy for patients
with advanced-stage melanoma. Nat Rev Clin Oncol. 21:173–184. 2024.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Russo V, Lunghi F, Fontana R and Bregni M:
A clinical study of a cell-based MAGE-A3 active immunotherapy in
advanced melanoma patients. J Cancer. 2:329–330. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lu C and Tan Y: Promising immunotherapy
targets: TIM3, LAG3, and TIGIT joined the party. Mol Ther Oncol.
32:2007732024. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ascierto PA, Agarwala SS, Blank C, Caracò
C, Carvajal RD, Ernstoff MS, Ferrone S, Fox BA, Gajewski TF, Garbe
C, et al: Perspectives in melanoma: Meeting report from the
melanoma bridge (December 2nd-4th, 2021, Italy). J Transl Med.
20:3912022. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ma B, Akosman B, Kamle S, Lee CM, He CH,
Koo JS, Lee CG and Elias JA: CHI3L1 regulates PD-L1 and
anti-CHI3L1-PD-1 antibody elicits synergistic antitumor responses.
J Clin Invest. 131:e1377502021. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Shah PD, Huang AC, Xu X, Orlowski R,
Amaravadi RK, Schuchter LM, Zhang P, Tchou J, Matlawski T, Cervini
A, et al: Phase I trial of autologous RNA-electroporated
cMET-directed CAR T cells administered intravenously in patients
with melanoma and breast carcinoma. Cancer Res Commun. 3:821–829.
2023. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hibler W, Merlino G and Yu Y: CAR NK cell
therapy for the treatment of metastatic melanoma: Potential &
prospects. Cells. 12:27502023. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Cui C, Wang X, Lian B, Ji Q, Zhou L, Chi
Z, Si L, Sheng X, Kong Y, Yu J, et al: OrienX010, an oncolytic
virus, in patients with unresectable stage IIIC-IV melanoma: A
phase Ib study. J Immunother Cancer. 10:e0043072022. View Article : Google Scholar : PubMed/NCBI
|
